IS5260A - Uppleystar sertralín samsetningar - Google Patents

Uppleystar sertralín samsetningar

Info

Publication number: IS5260A
Authority: IS; Iceland
Prior art keywords: formulations; dissolved sertraline; sertraline; dissolved; sertraline formulations
Prior art date: 1997-07-01

Application number

IS5260A

Other languages

English (en)

Inventor

Thomas Friesen Dwayne

Max Herbig Scott

Mysore Shanker Ravi

Blair West James

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-01

Filing date

1999-11-19

Publication date

1999-11-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS5260(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-11-19 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

1999-11-19 Publication of IS5260A publication Critical patent/IS5260A/is

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IS5260A 1997-07-01 1999-11-19 Uppleystar sertralín samsetningar IS5260A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5141397P	1997-07-01	1997-07-01
PCT/IB1998/000933 WO1999001120A1 (en)	1997-07-01	1998-06-15	Solubilized sertraline compositions

Publications (1)

Publication Number	Publication Date
IS5260A true IS5260A (is)	1999-11-19

Family

ID=21971159

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5260A IS5260A (is)	1997-07-01	1999-11-19	Uppleystar sertralín samsetningar

Country Status (34)

Country	Link
EP (1)	EP0999829A1 (is)
JP (1)	JP2000514100A (is)
KR (1)	KR100366373B1 (is)
CN (1)	CN1261794A (is)
AP (1)	AP1192A (is)
AR (3)	AR015917A1 (is)
AU (1)	AU742535B2 (is)
BG (1)	BG103918A (is)
BR (1)	BR9810739A (is)
CA (1)	CA2290974C (is)
CO (1)	CO4940495A1 (is)
DZ (1)	DZ2548A1 (is)
EA (1)	EA002481B1 (is)
HN (1)	HN1998000102A (is)
HR (1)	HRP980377A2 (is)
HU (1)	HUP0002236A3 (is)
ID (1)	ID23429A (is)
IL (1)	IL133076A (is)
IS (1)	IS5260A (is)
MA (1)	MA24587A1 (is)
NO (1)	NO996520L (is)
OA (1)	OA11243A (is)
PA (1)	PA8454301A1 (is)
PE (1)	PE97199A1 (is)
PL (1)	PL337804A1 (is)
SK (1)	SK181099A3 (is)
TN (1)	TNSN98124A1 (is)
TR (1)	TR199903297T2 (is)
TW (1)	TW550087B (is)
UA (1)	UA67741C2 (is)
UY (1)	UY25071A1 (is)
WO (1)	WO1999001120A1 (is)
YU (1)	YU68299A (is)
ZA (1)	ZA985708B (is)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DZ3227A1 (fr)	1999-12-23	2001-07-05	Pfizer Prod Inc	Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
US20030086972A1 (en) *	2000-08-09	2003-05-08	Appel Leah E.	Hydrogel-driven drug dosage form
AP2001002264A0 (en)	2000-08-30	2001-09-30	Pfizer Prod Inc	Sustained release formulations for growth hormone secretagogues.
US20040191207A1 (en) *	2003-03-31	2004-09-30	Lipari John M.	Alpha-hydroxy acid ester drug delivery compositions and methods of use
EP2117652B1 (en) *	2007-03-12	2013-09-25	DSM IP Assets B.V.	Cosmetic compositions
ES2564797T3 (es)	2009-08-19	2016-03-29	Eisai R&D Management Co., Ltd.	Composición farmacéutica con contenido en un derivado de quinolina
JPWO2011081117A1 (ja) *	2009-12-29	2013-05-09	興和株式会社	経口投与用固形医薬組成物
WO2011081118A1 (ja) *	2009-12-29	2011-07-07	興和株式会社	経口投与用医薬組成物
CN109908354A (zh) *	2017-12-12	2019-06-21	万特制药(海南)有限公司	盐酸舍曲林口服浓缩液及其制备工艺
CN114894736B (zh) *	2022-05-20	2025-03-21	中化地质矿山总局地质研究院	一种氯化物型卤水中硝酸根的测定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4803076A (en) *	1986-09-04	1989-02-07	Pfizer Inc.	Controlled release device for an active substance
DE69004529T2 (de) *	1989-08-30	1994-02-24	Pfizer	Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
ZA97976B (en) *	1996-04-05	1997-08-18	Alza Corp	Uniform drug delivery theraphy.

1998
- 1998-06-15 EP EP98923019A patent/EP0999829A1/en not_active Withdrawn
- 1998-06-15 HU HU0002236A patent/HUP0002236A3/hu unknown
- 1998-06-15 KR KR10-1999-7011361A patent/KR100366373B1/ko not_active Expired - Fee Related
- 1998-06-15 PL PL98337804A patent/PL337804A1/xx unknown
- 1998-06-15 CN CN98806763A patent/CN1261794A/zh active Pending
- 1998-06-15 BR BR9810739-9A patent/BR9810739A/pt not_active Application Discontinuation
- 1998-06-15 TR TR1999/03297T patent/TR199903297T2/xx unknown
- 1998-06-15 JP JP11506774A patent/JP2000514100A/ja active Pending
- 1998-06-15 WO PCT/IB1998/000933 patent/WO1999001120A1/en not_active Ceased
- 1998-06-15 ID IDW991701A patent/ID23429A/id unknown
- 1998-06-15 SK SK1810-99A patent/SK181099A3/sk unknown
- 1998-06-15 AU AU75448/98A patent/AU742535B2/en not_active Ceased
- 1998-06-15 IL IL13307698A patent/IL133076A/xx not_active IP Right Cessation
- 1998-06-15 EA EA199900962A patent/EA002481B1/ru unknown
- 1998-06-15 CA CA002290974A patent/CA2290974C/en not_active Expired - Fee Related
- 1998-06-15 UA UA99116391A patent/UA67741C2/uk unknown
- 1998-06-15 YU YU68299A patent/YU68299A/sh unknown
- 1998-06-25 AP APAP/P/1998/001280A patent/AP1192A/en active
- 1998-06-25 TW TW087110267A patent/TW550087B/zh active
- 1998-06-26 PE PE1998000573A patent/PE97199A1/es not_active Application Discontinuation
- 1998-06-29 AR ARP980103146A patent/AR015917A1/es not_active Application Discontinuation
- 1998-06-29 PA PA19988454301A patent/PA8454301A1/es unknown
- 1998-06-29 UY UY25071A patent/UY25071A1/es not_active IP Right Cessation
- 1998-06-30 MA MA25146A patent/MA24587A1/fr unknown
- 1998-06-30 TN TNTNSN98124A patent/TNSN98124A1/fr unknown
- 1998-06-30 DZ DZ980158A patent/DZ2548A1/xx active
- 1998-06-30 ZA ZA9805708A patent/ZA985708B/xx unknown
- 1998-07-01 CO CO98037137A patent/CO4940495A1/es unknown
- 1998-07-01 HR HR60/051,413A patent/HRP980377A2/hr not_active Application Discontinuation
- 1998-07-01 HN HN1998000102A patent/HN1998000102A/es unknown
1999
- 1999-11-19 IS IS5260A patent/IS5260A/is unknown
- 1999-11-23 BG BG103918A patent/BG103918A/xx unknown
- 1999-12-21 OA OA9900301A patent/OA11243A/en unknown
- 1999-12-28 NO NO996520A patent/NO996520L/no not_active Application Discontinuation
2003
- 2003-06-19 AR ARP030102180A patent/AR040280A2/es unknown
- 2003-06-19 AR ARP030102179A patent/AR040279A2/es unknown

Also Published As

Publication number	Publication date
AU7544898A (en)	1999-01-25
AR040279A2 (es)	2005-03-23
UY25071A1 (es)	2000-12-29
KR100366373B1 (ko)	2003-01-14
TW550087B (en)	2003-09-01
DZ2548A1 (fr)	2003-02-08
AP9801280A0 (en)	1998-06-30
UA67741C2 (uk)	2004-07-15
NO996520D0 (no)	1999-12-28
NO996520L (no)	2000-02-29
TNSN98124A1 (fr)	2005-03-15
BR9810739A (pt)	2000-09-12
HUP0002236A2 (hu)	2003-08-28
ZA985708B (en)	2000-01-10
WO1999001120A1 (en)	1999-01-14
CA2290974A1 (en)	1999-01-14
JP2000514100A (ja)	2000-10-24
CN1261794A (zh)	2000-08-02
AR015917A1 (es)	2001-05-30
IL133076A0 (en)	2001-03-19
CO4940495A1 (es)	2000-07-24
AU742535B2 (en)	2002-01-03
HN1998000102A (es)	1999-01-08
IL133076A (en)	2003-12-10
BG103918A (en)	2000-07-31
CA2290974C (en)	2004-04-27
HUP0002236A3 (en)	2003-12-29
EA199900962A1 (ru)	2000-08-28
EP0999829A1 (en)	2000-05-17
AP1192A (en)	2003-07-23
HRP980377A2 (en)	1999-04-30
TR199903297T2 (xx)	2000-07-21
EA002481B1 (ru)	2002-06-27
AR040280A2 (es)	2005-03-23
PA8454301A1 (es)	2000-09-29
MA24587A1 (fr)	1998-12-31
YU68299A (sh)	2002-06-19
SK181099A3 (en)	2000-07-11
KR20010013365A (ko)	2001-02-26
PE97199A1 (es)	1999-10-05
PL337804A1 (en)	2000-09-11
ID23429A (id)	2000-04-20
OA11243A (en)	2003-07-24

Publication	Publication Date	Title
MA24473A1 (fr)	1998-10-01	Formulations
IS5555A (is)	2000-06-30	Selekoxib lyfjablöndur
ID30031A (id)	2001-11-01	Formulasi-formulasi agrokimia
ID23546A (id)	2000-05-04	Formulasi-formulasi ziprasidon
NO20004240D0 (no)	2000-08-24	Formuleringer
ATE224703T1 (de)	2002-10-15	Brauseformulierungen
PT1130966E (pt)	2005-04-29	Formulacoes antiparasitarias
DE59802860D1 (de)	2002-02-28	Desinfektionsmittel
ID25533A (id)	2000-10-12	Formulasi 2-metil-tieno-benzodiazepin
DK0853945T3 (da)	2003-08-04	Flydende gonadotropinholdige formuleringer
NO992339L (no)	1999-11-16	Farmasöytiske formuleringer
DE69828330D1 (de)	2005-02-03	Aktiviertes Protein C Formulierungen
ATE227074T1 (de)	2002-11-15	Mikrokapsel-formulierungen
DE69812475T2 (de)	2004-01-29	Photoresistzusammensetzung
NO980546D0 (no)	1998-02-09	Farmasöytiske midler
DE69809717D1 (de)	2003-01-09	Konzentrierte desinfektionsmittel
CY2006006I1 (el)	2009-11-04	Πρωτεϊνικα σκευασματα
DE69935609D1 (de)	2007-05-03	Formulierungen enthaltend cefuroxim-axetil
ATE232683T1 (de)	2003-03-15	Mikrokapsel-formulierungen
DE69800779D1 (de)	2001-06-21	Photopolymerisierbare Zusammensetzung
DE69809633D1 (de)	2003-01-09	Photoresistzusammensetzung
NO995147D0 (no)	1999-10-22	Kontrastmidler
ID16781A (id)	1997-11-13	Formulasi-formulasi farmasi
IS5260A (is)	1999-11-19	Uppleystar sertralín samsetningar
NO20002590D0 (no)	2000-05-19	Formuleringer omfattende oppløst paroxetin